Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II study of flavopiridol in patients with advanced renal cell carcinoma: results of Southwest Oncology Group Trial 0109.
Van Veldhuizen PJ, Faulkner JR, Lara PN Jr, Gumerlock PH, Goodwin JW, Dakhil SR, Gross HM, Flanigan RC, Crawford ED; Southwest Oncology Group. Van Veldhuizen PJ, et al. Among authors: flanigan rc. Cancer Chemother Pharmacol. 2005 Jul;56(1):39-45. doi: 10.1007/s00280-004-0969-9. Epub 2005 Mar 25. Cancer Chemother Pharmacol. 2005. PMID: 15791454 Clinical Trial.
Phase II evaluation of merbarone in renal cell carcinoma.
Flanigan RC, Saiers JH, Wolf M, Kraut EH, Smith AY, Blumenstein B, Crawford ED. Flanigan RC, et al. Invest New Drugs. 1994;12(2):147-9. doi: 10.1007/BF00874446. Invest New Drugs. 1994. PMID: 7860233 Clinical Trial.
A phase II trial of continuous-infusion recombinant interleukin-2 in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.
Whitehead RP, Wolf MK, Solanki DL, Hemstreet GP 3rd, Benedetto P, Richman SP, Flanigan RC, Crawford ED. Whitehead RP, et al. Among authors: flanigan rc. J Immunother Emphasis Tumor Immunol. 1995 Aug;18(2):104-14. doi: 10.1097/00002371-199508000-00004. J Immunother Emphasis Tumor Immunol. 1995. PMID: 8574465 Clinical Trial.
238 results